Amarin Corp Plcuk (AMRN) Deferred Taxes (2013 - 2016)
Amarin Corp Plcuk (AMRN) reported Deferred Taxes of $11.9 million for Q4 2016, up 546.89% year-over-year from $1.8 million in Q1 2016, and up 1026.4% quarter-over-quarter from -$1.3 million in Q3 2016.
Amarin Corp Plcuk (AMRN) Deferred Taxes (2013 - 2016) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 4 years of Deferred Taxes data on file, last reported at $11.9 million in Q4 2016.
- Deferred Taxes for Q4 2016 came in at $11.9 million, up 546.89% year-over-year; the trailing twelve-month figure through Dec 2016 was $8.8 million (up 306.91% YoY), and the FY2019 annual result was $1.8 million, up 190.29% from the prior year.
- Deferred Taxes grew to $11.9 million in Q4 2016 per AMRN's latest filing, from -$1.3 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $11.9 million in Q4 2016 and troughed at -$3.9 million in Q1 2013.
- A 4-year average of -$200500.0 and a median of -$743500.0 in 2015 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2015 and 2016: Deferred Taxes sank 2151.61% in 2015, then soared 546.89% in 2016.
- A 4-year view of Deferred Taxes shows it stood at $2.3 million in 2013, then plunged by 262.26% to -$3.8 million in 2014, then advanced by 29.2% to -$2.7 million in 2015, then soared by 546.89% to $11.9 million in 2016.
- Business Quant data shows AMRN's Deferred Taxes at $11.9 million in Q4 2016, -$1.3 million in Q3 2016, and -$1.4 million in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | 1.48 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 159.00 Mn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | 137.00 Mn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | -315.00 Mn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | -176.00 Mn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 179.00 Mn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | -12.00 Mn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | 161.00 Mn |
| 10 | Amarin Corp Plcuk | 6.77 Bn | 6.59 Bn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 11.93 Mn |
| Sep 30, 2016 | -1.29 Mn |
| Jun 30, 2016 | -1.40 Mn |
| Mar 31, 2016 | -446,000.00 |
| Dec 31, 2015 | -2.67 Mn |
| Sep 30, 2015 | -851,000.00 |
| Jun 30, 2015 | -636,000.00 |
| Mar 31, 2015 | -95,000.00 |
| Dec 31, 2014 | -3.77 Mn |
| Sep 30, 2014 | 75,000.00 |
| Jun 30, 2014 | 31,000.00 |
| Mar 31, 2014 | -24,000.00 |
| Dec 31, 2013 | 2.32 Mn |
| Sep 30, 2013 | -1.55 Mn |
| Jun 30, 2013 | -887,000.00 |
| Mar 31, 2013 | -3.95 Mn |